MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial.

Angela Dispenzieri,Amrita Krishnan,Bonnie K. Arendt,Surendra Dasari,Yvonne A. Efebera,Nancy L. Geller,Sergio Giralt,Theresa Hahn,Mindy C. Kohlhagen,Heather Landau,Parameswaran Hari,Marcelo C. Pasquini,Muzaffar H. Qazilbash,Philip L. McCarthy,Nina Shah,David H. Vesole,Dan T. Vogl,Paul K. Wallace,Edward A. Stadtmauer,David L. Murray

MASS-FIX versus standard methods to predict for PFS and OS among multiple myeloma patients participating on the STAMINA trial.

2021

8009Background: Measuring response among patients with multiple myeloma is essential for the care of patients. Deeper responses have been associated with better progression free survival (PFS) and ...

Keywords:

Medicine
Internal medicine
Oncology
standard methods
Progression-free survival
Multiple myeloma

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations